TRAVERE THERAPEUTICS, INC. (TVTX) Gross profit 2016–2025
TRAVERE THERAPEUTICS, INC. (TVTX) annual gross profit history from SEC filings — each fiscal year as reported.
$480.4MFY2025 · since FY2016: $129.0M → $480.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $480.4M | +113.1% |
| FY2024 | $225.4M | +68.5% |
| FY2023 | $133.8M | +27.4% |
| FY2022 | $105.0M | -17.9% |
| FY2021 | $128.0M | -33.4% |
| FY2020 | $192.2M | +13.0% |
| FY2019 | $170.1M | +7.2% |
| FY2018 | $158.7M | +4.9% |
| FY2017 | $151.3M | +17.3% |
| FY2016 | $129.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice